Pharmacokinetics (PK) and Safety of the Antifibrotic Drug IDL-2965 in a Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study in Healthy Volunteers (HV) Compared to Therapeutic Plasma Concentrations in the Bleomycin Mouse Model of Lung Fibrosis